Rosen Law Firm reminded purchasers of PROCEPT BioRobotics Corporation common stock between February 28, 2024, and February 25, 2026, that they have until September 22, 2026, to seek appointment as lead plaintiff in a proposed securities class action. The lawsuit alleges that Procept used an extensive discount program to encourage customer bulk orders beyond procedure demand, pulling handpiece sales and revenue forward from future periods. The complaint claims the practice created more than 10,000 excess handpiece units in customer inventory by the end of the class period, overstated sales and system utilization, and left the company unable to meet its 2025 handpiece sales and revenue guidance. The lawsuit says investors suffered damages after the alleged facts entered the market. A class has not been certified, and investors need not serve as lead plaintiff to potentially participate in a future recovery.